Alvimopan

• Status: DMF No.: 028803 • Patent Expiration: US：2027.03.04; • Usage: Anti-infection

Brightgene Bio-Medical Technology Co.Ltd. Offers a wide range of anti-infective products which includes fondaparinux sodium. It belongs to cardiovascular category. Contact us for more information.

• Status:  • DMF No.:031449 • ASMF Approved • MF No.: 230MF10169 • Patent Expiration: Off-patent • Usage:Antifungal

• Status: DMF No.: 028314 • Patent Expiration: Off-patent • Usage: Antifungal

• Status: Pilot • Patent Expiration: US: 2027.1.1 • Usage: Anti-infection

• Status: Validated • Patent Expiration: ODE：2022.10.23；NCE：2020.10.23 • Usage: Oncology

• Status: DMF No.:032346 • Patent Expiration: Off-patent • Usage: Antifungal

• Status: DMF No.:030886 • Patent Expiration: Off-patent • Usage: Antifungal

• Status: DMF No. :033904 • Patent Expiration: US：2021.01.27； CN：2020.11.23 • Usage:Selective relaxant binding agent 

• Status: Validated • Patent Expiration: CN：2021.7；US：2032.8 • Usage: AntiHBV

• Status: Validated, DMF will be ready to file at Q1,2021 • Patent Expiration: GAIN：2024.5.23 • Usage: Anti-infection

• Status: Validated and DMF ready • Patent Expiration: Off-patent • Usage: Anti-infection